HIGHLIGHTS
- who: Xiaojuan Deng and collaborators from the Department of Pharmacy, Geriatric Hospital of Hainan, Haikou, Hainan, China have published the Article: ACEI and ARB Lower the Incidence of End-Stage Renal Disease among Patients with Diabetic Nephropathy: A Meta-analysis, in the Journal: Computational and Mathematical Methods in Medicine of 31/05/2022
- what: This study explores the effects of Angiotensin-Converting Enzyme Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARB) on the incidence of end-stage renal disease (ESRD) in diabetic nephropathy (DN) patients.
SUMMARY
In recent years, the incidence of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.